March 12, 2019
Pfizer’s Trazimera, cancer biosimilar to Genentech Inc’s Herceptin, approved in USA
Pfizer got approval for Trazimera n USA for the treatment of human epidermal growth factor receptor-2 (HER2) overexpressing breast cancer and HER2 adenocarcinoma.